KamTek Revenue and Competitors

Since its establishment in 1992, KTI has enjoyed over 25 years of participating in a wide range of biotech/clinical research projects working with many regional and national biotech businesses and governmental agencies. Dedicated to excellence in advancing fields of biotechnology and biomedical research, KamTek has always attracted talent and derived its strength from a highly innovative and professional team with expertise in newly evolving areas of Molecular Biology, Immunology, Microbiology, Cell Biology, Genetics, Virology, and Tumor Biology. KamTek also maintains a perfectly equipped bio-repository designed to manage safety and integrity of bio-specimens, a crucial ingredient of any biomedical/biotech research operation. At KamTek state-of-the-art biotech projects are executed by highly trained and dedicated staff in collaboration with instrumentation experts, information technology professionals and various other service providers working as a cohesive team. KTI operates efficiently with a diligent team, many of whom are cross-trained, and a highly experienced group of close, collaborative Associates. KTI’s ever-evolving, state-of-the-art services have allowed it to maintain a sound financial base. The company has also attracted angel investments to supplement government funding and uses internal resources to support its key projects. KTI has also received grants from National Institute of Health under SBIR program.